Changchun Hi-Tech: application for clinical trial of Jinna monoclonal antibody for injection by holding subsidiary is approved

[Changchun Hi-tech: application for Clinical trial of Ginatumab for injection by holding subsidiary approved] May 25, Changchun Hi-Tech announced that the application for clinical trial of Ginatumab for injection by holding subsidiary was approved.